Migraine & Omeprazole: Potential Interactions & What to Know

Co‑administration of migraine medications and omeprazole (a proton pump inhibitor) requires individualized assessment due to potential pharmacokinetic and pharmacodynamic interactions.

Common Migraine Medication Classes & Interaction Risks

NSAIDs (ibuprofen, naproxen, aspirin)

  • Risk: Both NSAIDs and PPIs can cause GI irritation; PPIs are often co‑prescribed to protect against NSAID‑induced ulcers.
  • Interaction: Minimal pharmacokinetic interaction. Omeprazole may slightly increase ibuprofen absorption (negligible clinically).

Triptans (sumatriptan, rizatriptan, eletriptan)

  • Metabolism: Sumatriptan – MAO‑A; rizatriptan – MAO‑A; eletriptan – CYP3A4.
  • Omeprazole: Weak CYP2C19 inhibitor, minimal CYP3A4/MAO‑A effect.
  • Clinical significance: No major interaction documented. Monitor for efficacy changes.

Ergot Derivatives (ergotamine, dihydroergotamine)

  • CYP3A4 substrates; omeprazole not a strong inhibitor. Low interaction risk.

CGRP Antagonists (gepants: ubrogepant, rimegepant; mAbs: erenumab, fremanezumab)

  • Gepants: CYP3A4 substrates (avoid strong inhibitors/inducers). Omeprazole – no significant effect.
  • Monoclonal antibodies: no CYP metabolism; no interaction.

Preventive Medications Often Used with PPIs

  • Topiramate, valproate, propranolol, amitriptyline: No major omeprazole interactions.
  • Candesartan: No interaction.

Special Considerations

  • Gastric pH changes: Omeprazole raises gastric pH → may affect absorption of pH‑dependent drugs (e.g., ketoconazole, itraconazole, erlotinib). Most migraine drugs not significantly affected.
  • Long‑term PPI use: Associated with B12 deficiency, hypomagnesemia, fracture risk, C. diff infection – monitor if chronic.
  • Rebound acid hypersecretion on discontinuation – taper if used >8 weeks.

Action Steps

  1. Provide complete medication list to prescriber/pharmacist.
  2. Use one pharmacy for interaction screening.
  3. Report new/worsening headache patterns, GI symptoms.
  4. Do not stop/change doses without clinician guidance.

Most migraine therapies can be safely combined with omeprazole, but professional review ensures optimal safety and efficacy.

Migraine - Related Articles